This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times.
Clinical trial NCT05858450 · COMPLETED
Trial details
- NCT number
- NCT05858450
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-05
- Primary completion
- 2023-05-12
- Enrollment
- 3442996
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.